CONNECT BIOPHARMA HOLD

Connect Biopharma to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

09 2 2022 06:00:00 提供 Nasdaq GlobeNewswire

Connect Biopharma Presents Data and Analyses from the Global Phase 2b Trial of CBP-201 at the Maui Derm Conference

24 1 2022 06:00:00 提供 Nasdaq GlobeNewswire

Connect Biopharma Reports Detailed Positive Dataset from the Global Phase 2b Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis

05 1 2022 06:00:01 提供 Nasdaq GlobeNewswire

Connect Biopharma to Host Conference Call on January 5 at 8:30 AM ET to Review Detailed Data from the Global Phase 2b Trial of CBP-201

04 1 2022 15:05:00 提供 Nasdaq GlobeNewswire

Connect Biopharma Expands Executive Leadership Team with Hire of Chief Financial Officer

22 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

Connect Biopharma Completes Enrollment of CBP-307 Global Phase 2 Clinical Trial in Moderate-to-Severe Ulcerative Colitis

19 11 2021 07:00:00 提供 Nasdaq GlobeNewswire

Connect Biopharma Reports Positive Top-Line Results from the Global Phase 2 Clinical Trial of CBP-201 in Patients with Moderate-to-Severe Atopic Dermatitis

18 11 2021 15:02:00 提供 Nasdaq GlobeNewswire

Connect Biopharma to Participate at Upcoming Conferences

11 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

Connect Biopharma to Participate at the Jefferies Virtual China Biotech Summit

19 10 2021 07:00:02 提供 Nasdaq GlobeNewswire

Connect Biopharma Announces First Subject Dosed in Phase 2 Trial Evaluating CBP-201 in Adult Patients with Chronic Rhinosinusitis with Nasal Polyps

08 9 2021 07:00:03 提供 Nasdaq GlobeNewswire

Connect Biopharma Provides Business Update and Reports First Half 2021 Financial Results

31 8 2021 15:05:00 提供 Nasdaq GlobeNewswire

Connect Biopharma to Host First Half 2021 Financial Results Conference Call on September 1, 2021

25 8 2021 07:00:00 提供 Nasdaq GlobeNewswire

Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member

23 8 2021 15:05:00 提供 Nasdaq GlobeNewswire